AI and privacy

AI in pharmacy: what to check before adopting it

The new activities add documentation, and AI may seem an obvious answer. It can help draft, transcribe and summarize, but it does not replace the pharmacist’s assessment or their obligations.

Unless stated otherwise, the pharmacist’s new activities described here apply from December 9, 2026.

In brief
  • To our knowledge, the Ordre has not published a specific rule on AI, but professional duties and privacy laws apply.
  • Law 25 requires a privacy impact assessment for certain technology projects.
  • The professional remains responsible for what goes into the file.

Is there a rule from the Ordre on AI?

To our knowledge, the Ordre has not published a specific rule on AI. It has, however, addressed the topic in a training podcast with the A.P.E.S. Professional duties continue to apply, and the pharmacist remains responsible for what goes into the file.

What does Law 25 ask for?

Québec’s private sector law notably provides for a privacy impact assessment for information system projects that process personal information, and specific rules when a decision is based exclusively on automated processing. A pharmacy’s health information also falls under the health information act, which is worth checking with your advisor.

What do the privacy commissioners say?

In September 2026, Canada’s privacy commissioners adopted a joint resolution on AI in health. Its principles notably cover privacy, validity and reliability, safety, transparency and accountability. It draws attention to human oversight and to staff using unauthorized AI tools.

What about AI transcription?

Québec.ca describes conditions for transcription tools: a certification obtained by the vendor, a privacy impact assessment, informing the patient and validation of the text by the professional. That page does not specifically mention pharmacists, but these questions are worth asking any vendor.

Seven questions before adopting a tool

  • Which tools are used, by whom and for which tasks, including unauthorized uses?
  • What information do they process, and where is it hosted?
  • Is it used to train a model?
  • Who checks the result before it is used, and how can it be challenged?
  • What privacy assessment is required before adoption?
  • What does the contract say about use, retention, audit and confidentiality?
  • What happens if a decision is based exclusively on automated processing?

Would you like an outside view on these questions? See our support.

Sources: OPQ and A.P.E.S., podcast on AI in pharmacy (in French) · Joint resolution of Canada’s privacy commissioners on AI in health, September 15, 2026 · CAI, joint resolution on AI in health, October 29, 2026 (in French) · CAI, main changes under Law 25 (in French) · Québec.ca, AI transcription (in French)

General information based on the publications cited. This text does not replace professional or legal advice, or the Ordre’s guides.

Read next

Bill 67 / December 9, 2026

Next, see where your team stands.

Start with the free assessment. No account, and your answers stay on your device.